Consenting participants will have their deidentified sequence data used for research and will also have the chance to learn if they have clinically actionable results.
The mCODE team recently released standards for inputting genomic and other data into patient records to boost patient record transferability and trial participation.
Before broad implementation, the healthcare system will gauge the feasibility of the screening program, patient impact, and cost-benefit in a pilot phase.
The partnership has allowed Philips to provide a single view of cancer patient's status, including genomic test results, through the FDA-cleared IntelliSite Pathology Solution.
The health system hopes to pair the data with nearly three decades worth of electronic health records as well as medical histories provided by contributors.
Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
